The GST council has announced a reduction in tax rates for cancer drugs from 12% to 5%, and for namkeens from 18% to 12%. A group of ministers will provide recommendations on reducing rates for medical health insurance by October. The compensation cess collection is scheduled to end by March 2026.
Related Posts
Input tax credit removal set to hit commercial realty companies
- staff
- February 3, 2025
- 0
Availability of ITC on construction costs has been restricted retroactively from July 1, 2017, impacting commercial real estate companies. This amendment overturns a Supreme Court […]
When Narayana Murthy touched Ratan Tata’s feet
Ratan Tata, Chairman Emeritus of Tata Sons, passed away in Mumbai, marking the end of a remarkable corporate journey. A few years ago, Narayna Murthy […]
‘India needs 1.2-1.5 tax buoyancy for 7% growth’
- staff
- February 26, 2025
- 0
India needs a tax buoyancy of 1.2-1.5 to achieve a 6.5-7% growth rate, according to an EY report. To support this growth, the government may […]